Gsk Year End Results 2025

Gsk Year End Results 2025

Gsk Year End Results 2025. Gsk (gsk) announced its q4 2023 results, exceeding estimates with a 15% yoy growth in sales and citing 12 major product launches from 2025. Gsk ceo emma walmsley noted that the company plans to launch at least 12 new drugs from 2025 for infectious diseases, hiv, respiratory, and oncology.


Gsk Year End Results 2025

Gsk plc gsk reported core earnings of $1.09 per american. Important step towards gsk’s global target of 100% purchased renewable electricity across all sites by end 2025.

Gsk Year End Results 2025 Images References :